Allahabad HC Puts On Hold UP’s Order To Suspend Sanjay Gandhi Hospital’s Licence

Lucknow/Amethi: The Lucknow bench of Allahabad High Court on Wednesday stayed the Uttar Pradesh government’s order suspending the licence of Sanjay Gandhi Hospital in Amethi.

A division bench of Justices Vivek Chaudhary and Manish Kumar said that inquiry against the hospital would go on. The bench also asked the state government to file its counter affidavit.

The bench was hearing a petition filed by the Sanjay Gandhi Hospital administration against the government’s order.

On September 18, the health department suspended the licence of Sanjay Gandhi Hospital in Munshiganj area of Amethi and halted OPD and emergency services, days after the death of a woman patient following an operation.

The hospital is run by Sanjay Gandhi Memorial Trust (SGMT) headed by Congress leader Sonia Gandhi.

Manoj Muttu, administrator of the trust, told PTI that a copy of the court’s order will be submitted to the chief medical officer of Amethi and as per the CMO’s directions functioning of the hospital will resume.

However, Muttu said he would like the hospital to resume functioning from Thursday.

On September 27, over 400 employees of the hospital sat on a dharna against the suspension of its licence. Local Congress leaders also staged a protest outside the CMO’s office.

The woman patient, Divya (22) who was admitted to the Sanjay Gandhi Hospital on September 14, went into a coma during a surgery. Her family members alleged that she was kept at the hospital for more than 30 hours before being referred to Lucknow where she died on September 16.

The next day, an FIR of causing death by negligence was registered against four employees of the hospital, including its chief executive officer.

Related Posts

  • Pharma
  • December 23, 2024
  • 14 views
Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

  • Pharma
  • December 23, 2024
  • 42 views
NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

India-Latin America trade and collaboration prospects discussed at Kerala University conference

India-Latin America trade and collaboration prospects discussed at Kerala University conference

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt